fenofibrate has been researched along with Complications, Pregnancy in 5 studies
Pharmavit: a polyvitamin product, comprising vitamins A, D2, B1, B2, B6, C, E, nicotinamide, & calcium pantothene; may be a promising agent for application to human populations exposed to carcinogenic and genetic hazards of ionizing radiation; RN from CHEMLINE
| Excerpt | Relevance | Reference |
|---|---|---|
| " Prenatal fenofibrate administration attenuated detrimental effects induced by MIA on both the schizophrenia-like behavioral phenotype and dopamine transmission in male offspring." | 7.91 | The PPARα agonist fenofibrate attenuates disruption of dopamine function in a maternal immune activation rat model of schizophrenia. ( Aroni, S; De Felice, M; Devoto, P; Fanni, S; Frau, R; Melis, M; Muntoni, AL; Pistis, M, 2019) |
| "Fenofibrate was used safely and successfully during pregnancy in this case of hypertriglyceridemia-associated pancreatitis refractory to conservative measures." | 7.77 | Hyperlipidemia-associated pancreatitis in pregnancy managed with fenofibrate. ( Lorenz, RP; Smith, JM; Whitten, AE, 2011) |
| "Bexarotene is a synthetic retinoid from the subclass of retinoids called rexinoids which selectively activate retinoid X receptors." | 5.39 | U.K. consensus statement on safe clinical prescribing of bexarotene for patients with cutaneous T-cell lymphoma. ( Azurdia, R; Cowan, R; Eagle, M; Gallop-Evans, E; Graham-Brown, R; Illidge, T; Morris, S; Parry, E; Scarisbrick, JJ; Soran, H; Wachsmuth, R; Wain, EM; Whittaker, S; Wierzbicki, AS, 2013) |
| " Prenatal fenofibrate administration attenuated detrimental effects induced by MIA on both the schizophrenia-like behavioral phenotype and dopamine transmission in male offspring." | 3.91 | The PPARα agonist fenofibrate attenuates disruption of dopamine function in a maternal immune activation rat model of schizophrenia. ( Aroni, S; De Felice, M; Devoto, P; Fanni, S; Frau, R; Melis, M; Muntoni, AL; Pistis, M, 2019) |
| "Fenofibrate was used safely and successfully during pregnancy in this case of hypertriglyceridemia-associated pancreatitis refractory to conservative measures." | 3.77 | Hyperlipidemia-associated pancreatitis in pregnancy managed with fenofibrate. ( Lorenz, RP; Smith, JM; Whitten, AE, 2011) |
| "Bexarotene is a synthetic retinoid from the subclass of retinoids called rexinoids which selectively activate retinoid X receptors." | 1.39 | U.K. consensus statement on safe clinical prescribing of bexarotene for patients with cutaneous T-cell lymphoma. ( Azurdia, R; Cowan, R; Eagle, M; Gallop-Evans, E; Graham-Brown, R; Illidge, T; Morris, S; Parry, E; Scarisbrick, JJ; Soran, H; Wachsmuth, R; Wain, EM; Whittaker, S; Wierzbicki, AS, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Grady, J | 1 |
| Clifford, C | 1 |
| Treadwell, MC | 1 |
| Parikh, ND | 1 |
| Satishchandran, A | 1 |
| De Felice, M | 1 |
| Melis, M | 1 |
| Aroni, S | 1 |
| Muntoni, AL | 1 |
| Fanni, S | 1 |
| Frau, R | 1 |
| Devoto, P | 1 |
| Pistis, M | 1 |
| Whitten, AE | 1 |
| Lorenz, RP | 1 |
| Smith, JM | 1 |
| Scarisbrick, JJ | 1 |
| Morris, S | 1 |
| Azurdia, R | 1 |
| Illidge, T | 1 |
| Parry, E | 1 |
| Graham-Brown, R | 1 |
| Cowan, R | 1 |
| Gallop-Evans, E | 1 |
| Wachsmuth, R | 1 |
| Eagle, M | 1 |
| Wierzbicki, AS | 2 |
| Soran, H | 1 |
| Whittaker, S | 1 |
| Wain, EM | 1 |
| Mikhailidis, DP | 1 |
| Wray, R | 1 |
1 review available for fenofibrate and Complications, Pregnancy
| Article | Year |
|---|---|
Drug treatment of combined hyperlipidemia.
Topics: Acute Disease; Clofibric Acid; Diabetes Mellitus, Type 2; Female; Fenofibrate; Humans; Hydroxymethyl | 2001 |
4 other studies available for fenofibrate and Complications, Pregnancy
| Article | Year |
|---|---|
Use of fenofibrate for intrahepatic cholestasis of pregnancy.
Topics: Cholestasis, Intrahepatic; Female; Fenofibrate; Humans; Pregnancy; Pregnancy Complications | 2023 |
The PPARα agonist fenofibrate attenuates disruption of dopamine function in a maternal immune activation rat model of schizophrenia.
Topics: Animals; Disease Models, Animal; Dopamine; Female; Fenofibrate; Male; Neuroimmunomodulation; Neurons | 2019 |
Hyperlipidemia-associated pancreatitis in pregnancy managed with fenofibrate.
Topics: Adult; Blood Glucose; Female; Fenofibrate; Humans; Hypertriglyceridemia; Hypolipidemic Agents; Infan | 2011 |
U.K. consensus statement on safe clinical prescribing of bexarotene for patients with cutaneous T-cell lymphoma.
Topics: Adult; Amylases; Anticarcinogenic Agents; Bexarotene; Blood Cell Count; Blood Glucose; Cholesterol, | 2013 |